Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction.
第一作者:
Yuki,Kita
第一单位:
Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
作者:
主题词
癌, 移行细胞(Carcinoma, Transitional Cell);人类(Humans);肾疾病(Kidney Diseases);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1016/j.urolonc.2022.04.005
PMID
35551861
发布时间
2022-09-22
- 浏览0

Urologic oncology
410.e11-410.e18页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文